The Best 3 Marijuana Stocks For Your 2024 WatchlistWhat will happen to marijuana stocks if cannabis does not get rescheduled? Some see this as a possibility and investors want to be prepared. With all the recent talks of cannabis being dropped from a scheduled 1 to a class 3 substance it has led to a rise in trading. The speculation of what’s next to come is also feeding into momentum pouring into the sector.The goal should be the reclassification of cannabis and putting it into the same place as alcohol an ...

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...

SMITHS FALLS, ON, May 7, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) today confirmed that Canopy USA, LLC ("Canopy USA") has exercised the options to acquire Wana and Jetty (each as defined below). The exercise of these options is a critical next step to enable Canopy USA to fulfill its intent to establish a leading, brand-focused powerhouse. It is also expected that once completed, these acquisitions will enable Canopy USA to realize compelling ...

C$27.5 Millon of Debt Extended from 2025 to 2029 Providing Additional Balance Sheet Flexibility SMITHS FALLS, ON, May 3, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC), today announced that on May 2, 2024, it entered into an exchange and subscription agreement (the "Agreement") with a single institutional investor (the "Investor") pursuant to which Canopy Growth is expected to receive gross proceeds of approximately US$50 million and exchange appro ...

Investors are taking profits on marijuana stocks today, but the long-term trend still looks up.Easy come, easy go. Yesterday, shares of cannabis companies like Canopy Growth (CGC -25.96%), Tilray Brands (TLRY -17.01%), and Cronos Group (CRON -7.14%) all soared on news that the U.S. Drug Enforcement Administration (DEA) has agreed to recommend downgrading marijuana from a Schedule I drug to a Schedule III drug. Already today, the high is starting to wear off.As of 11:15 a.m. ET Wednesday, Canopy Growth stock ...

Cannabis stocks are falling on Wednesday as shares of marijuana companies are giving up some of the massive gains they saw yesterday.That rally came about after reports claimed the Biden Administration is moving forward with plans to reschedule cannabis from a Schedule I drug to a Schedule III drug. This would see it face fewer restrictions on research and open up tax breaks for companies in the field.This decision is a major win for cannabis stocks and it resulted in many shares climbing higher during norm ...

Following a major breakthrough, cannabis operators such as Canopy Growth (NASDAQ:CGC) saw their shares rise dramatically yesterday. As InvestorPlace’s Shrey Dua reported, President Joe Biden’s administration is moving to reschedule marijuana as a Schedule III substance. At the moment, cannabis carries the tougher Schedule I classification. With the decision potentially opening doors, CGC stock call options look mighty tempting.Fundamentally, the Schedule III downgrade would put marijuana on the same legal l ...

OlegMalyshev Listen here or on the go via Apple Podcasts and Spotify. Mario Naric, CEO and Founder of Motif Labs, discusses being in the shakeout phase of cannabis in Canada (1:00). Staying private while public companies suffer (5:25). How to grow market share in Canada (12:53). Near-term reality for big Canadian LPs like Tilray and Canopy Growth (18:00). Different products for different markets within US and Canada (23:20). Where should investors allocate their capital in this space? (40:40) Transcr ...

A January Pew Research survey indicates that 88% of U.S. adults support the legalization of cannabis for medicinal use. Further, 57% adults opine that the legalization should be for recreational use as well. The continued change in public opinion in favor of legalization might imply that it could have a chance of happening relatively soon at the federal level. With the presidential election due later this year, it’s a good time to look at cannabis stocks to buy for multibagger returns.While there are growin ...

Is Canopy Growth closer to entering the U.S. cannabis market?Canopy Growth (CGC 2.41%) is moving ahead with its plans for Canopy USA. After shareholders voted overwhelmingly in favor of its latest growth strategy for the U.S. pot market, the company is ready to take the next steps. Here's a look at what will those steps be, what they mean for investors, and whether these developments make Canopy Growth a better buy moving forward.What's next for Canopy Growth?Now that it has obtained shareholder approval, C ...